These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 22000652)

  • 81. Clinical evidence for the influence of uric acid on hypertension, cardiovascular disease, and kidney disease: a statistical modeling perspective.
    Short RA; Tuttle KR
    Semin Nephrol; 2005 Jan; 25(1):25-31. PubMed ID: 15660331
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Treatment of asymptomatic hyperuricemia in chronic kidney disease: A new target in an old enemy - A review.
    Ramirez MEG; Bargman JM
    J Adv Res; 2017 Sep; 8(5):551-554. PubMed ID: 28748121
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Direct Relationship Between Uric Acid and C-Reactive Protein and Its Implication in the Chronic Kidney Disease.
    Jeena J; Manhas S; Prasad R; Prasad S; Gupta R
    Indian J Clin Biochem; 2022 Jul; 37(3):365-369. PubMed ID: 35873604
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Uric Acid Puzzle: Dual Role as Anti-oxidantand Pro-oxidant.
    Kang DH; Ha SK
    Electrolyte Blood Press; 2014 Jun; 12(1):1-6. PubMed ID: 25061467
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Integrin αM promotes macrophage alternative M2 polarization in hyperuricemia-related chronic kidney disease.
    Liu J; Guo F; Chen X; Fu P; Ma L
    MedComm (2020); 2024 Jul; 5(7):e580. PubMed ID: 38911067
    [TBL] [Abstract][Full Text] [Related]  

  • 86. [An attempt to determine the value of the so-called clearance test for uric acid in certain renal diseases].
    TUSZKIEWICZ A; KRAWCZYNSKI J; RYCAJ M; SZEWCZYKOWSKI W; DREWNOWSKA I; KUJAWA R; PASTUSZANKA S
    Pol Arch Med Wewn; 1958; 28(4):574-7. PubMed ID: 13601294
    [No Abstract]   [Full Text] [Related]  

  • 87. Uric acid nephropathy: management pearls.
    Nally JV
    Cleve Clin J Med; 1990 Sep; 57(6):505-7. PubMed ID: 2268960
    [No Abstract]   [Full Text] [Related]  

  • 88. Kidney in old age.
    Maertens S; Van Den Noortgate NJ
    Acta Clin Belg; 2008; 63(1):8-15. PubMed ID: 18386760
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Uric acid and chronic kidney disease: A time to act?
    Bellomo G
    World J Nephrol; 2013 May; 2(2):17-25. PubMed ID: 24175261
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Microvascular disease and its role in the brain and cardiovascular system: a potential role for uric acid as a cardiorenal toxin.
    Kanbay M; Sánchez-Lozada LG; Franco M; Madero M; Solak Y; Rodriguez-Iturbe B; Covic A; Johnson RJ
    Nephrol Dial Transplant; 2011 Feb; 26(2):430-7. PubMed ID: 20935013
    [TBL] [Abstract][Full Text] [Related]  

  • 91. High Water Intake and Progression of Chronic Kidney Diseases.
    Choi HY; Park HC; Ha SK
    Electrolyte Blood Press; 2015 Dec; 13(2):46-51. PubMed ID: 26848303
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Effects of uric-acid-lowering therapy on renal outcomes: the future looks promising.
    Filiopoulos V
    Hypertens Res; 2016 Aug; 39(8):578-80. PubMed ID: 27194572
    [No Abstract]   [Full Text] [Related]  

  • 93. Uric acid nephropathy in leukemia. The use of acetazolamide in its management.
    HERRINGTON RT; FALLON HJ
    N Engl J Med; 1962 May; 266():934-5. PubMed ID: 13906831
    [No Abstract]   [Full Text] [Related]  

  • 94. Uric acid nephropathy after radiation therapy in a patient with chronic lymphocytic leukemia.
    Theodossiou C; Troy KM; Cuttner J
    Am J Hematol; 1992 Aug; 40(4):320. PubMed ID: 1503091
    [No Abstract]   [Full Text] [Related]  

  • 95. Administration of retinoic acid to pregnant mice increases the number of fetal mouse glomeruli.
    Fukunaga S; Ogawa N; Matsumoto A; Ito T; Tanabe K; Otani H
    Biochem Biophys Rep; 2022 Jul; 30():101245. PubMed ID: 35280524
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Exploring multifaceted factors in chronic kidney disease risk: A comprehensive analysis of biochemistry, lifestyle, and inflammation in elderly Chinese individuals.
    Cardona F
    World J Clin Cases; 2024 Feb; 12(5):1033-1035. PubMed ID: 38414610
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Kidney disease in disadvantaged populations.
    Martins D; Agodoa L; Norris K
    Int J Nephrol; 2012; 2012():469265. PubMed ID: 22567281
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Preservation of uric acid infarcts in the museum.
    NEUMARK E
    Lab Invest; 1952; 1(3):376-7. PubMed ID: 14955974
    [No Abstract]   [Full Text] [Related]  

  • 99. Uric Acid and Contrast-Induced Nephropathy: Diagnostic Marker, Therapeutic Target, or Innocent Bystander?
    Canpolat U; Çöteli C; Kivrak A
    Angiology; 2017 Aug; 68(7):648-649. PubMed ID: 27178718
    [No Abstract]   [Full Text] [Related]  

  • 100. Reply to: Uric Acid and Contrast-Induced Nephropathy: Diagnostic Marker, Therapeutic Target, or Innocent Bystander?
    Sahan DO; Kanbay M
    Angiology; 2017 Aug; 68(7):650. PubMed ID: 28488888
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.